Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures

Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is a rare hereditary kidney cancer syndrome in which affected individuals are at risk of skin and uterine leiomyomatosis and kidney cancer. HLRCC-asso...

Source: BMC Urology - June 10, 2019 Category: Urology & Nephrology Authors: Inkeun Park, Young Sup Shim, Heounjeong Go, Bum Sik Hong and Jae Lyun Lee Tags: Case report Source Type: research